What top creators are saying about Sage Therapeutics, Inc.(SAGE)
Biopharmaceutical company behind the drug Zerzovay.
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Not enough scored insights about Sage Therapeutics, Inc. in the last 30 days yet.
Top creators covering Sage Therapeutics, Inc. (SAGE)
The 1 sources with the most insights about Sage Therapeutics, Inc. on Kazuha.
Latest insights about Sage Therapeutics, Inc. (SAGE)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Saturday, November 1, 2025
A high-profile, organic celebrity endorsement for its postpartum depression drug, Zerzovay, could significantly boost public awareness and is viewed as a positive indicator for market potential.
Saturday, November 1, 2025
A high-profile, organic celebrity endorsement for its postpartum depression drug, Zerzovay, could significantly boost public awareness and is viewed as a positive indicator for market potential.
Discussed alongside Sage Therapeutics, Inc. (SAGE)
Other assets that creators frequently mention in the same content as Sage Therapeutics, Inc..
Frequently asked
Which podcasters and creators cover Sage Therapeutics, Inc. (SAGE) the most?
The most active sources covering Sage Therapeutics, Inc. (SAGE) on Kazuha are The New York Times. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Sage Therapeutics, Inc. (SAGE) are on Kazuha?
Kazuha has indexed 1 AI-extracted insight about Sage Therapeutics, Inc. (SAGE) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Sage Therapeutics, Inc. (SAGE)?
Creators covering Sage Therapeutics, Inc. (SAGE) most frequently also discuss DIS, LGF.A, BIIB. See the "Discussed alongside" section above for full asset pages.